ÁÖ¸Þ´º

Ȩ¾ÆÀÌÄÜ  >  À̽´

[¿¬±¸] "Á¦´ëÇ÷ À¯ÀüÀÚ·Î ¼Ò¾Æºñ¸¸ ¿¹Ãø °¡´É"

±è¼ºÈ­ ±âÀÚksh2@healthi.kr ÀÔ·Â : 2019-07-26 09:54  | ¼öÁ¤ : 2019-07-26 09:54

³×À̹ö ÆäÀ̽ººÏ ¹êµå ±¸±Û Æ®À§ÅÍ ÇÉÅÍ·¹½ºÆ® īī¿À½ºÅ丮 īī¿À¸µÅ© Àμ⠴ٿî·Îµå È®´ë Ãà¼Ò

 

»çÁø=123RF

 

[Çコ¾Ø¶óÀÌÇÁ ±è¼ºÈ­ ±âÀÚ] ÀÌ´ë¸ñµ¿º´¿ø(º´¿øÀå ÇÑÁ¾ÀÎ)Àº »êºÎÀΰú ±è¿µÁÖ ±³¼öÆÀÀÌ Á¦´ëÇ÷ À¯ÀüÀÚ¸¦ ÅëÇØ ¾î¸°ÀÌÀÇ ºñ¸¸À» ¿¹ÃøÇÒ ¼ö ÀÖ´Ù´Â ¿¬±¸ °á°ú¸¦ ¹ßÇ¥Çß´Ù°í 25ÀÏ ¹àÇû´Ù.

 

±è¿µÁÖ ±³¼öÆÀÀº ¿¬±¸¸¦ ÅëÇØ Á¦´ëÇ÷ ³» ¸á¶ó³ëÄÚ¸£Æ¾ 4 ¼ö¿ëü(Melanocortin 4 receptor, MC4R)¿Í °£¼¼Æ÷ ÇÙÀÎÀÚ 4 ¾ËÆÄ(Hepatocyte nuclear factor 4 alpha, HNF4A) À¯ÀüÀÚ°¡ 7~9¼¼ ¾Æµ¿ Ç÷¾×ÀÇ Æ®¸®±Û¸®¼¼¶óÀ̵åÀÇ ¼öÁØ ¹× üÁú·® Áö¼ö¿Í °ü·ÃµÅ ÀÖ´Ù´Â Á¡À» È®ÀÎÇß´Ù.

 

À¯ÀüÀÚ ¸ÞƿȭÀÇ º¯È­´Â ÁÁÁö ¾ÊÀº Àڱà ³» ȯ°æ¿¡ ÀÇÇØ ³ªÅ¸³ª´Â °ÍÀ¸·Î, ÀÌ·¯ÇÑ È¯°æ¿¡¼­ ž ¾Æ±â°¡ ¼ºÀÎÀÌ µÇ¾úÀ» ¶§ ¸¸¼ºÁúȯ À¯º´À²ÀÌ ³ô¾ÆÁø´Ù´Â °ÍÀÌ ÇаèÀÇ Á¤¼³ÀÌÁö¸¸ À̸¦ ¸íÈ®È÷ ±Ô¸íÇÑ ¿¬±¸ °á°ú´Â ¾ø¾ú´Ù.

 

±è¿µÁÖ ±³¼öÆÀÀº ÀÌÈ­ Ãâ»ý ¹× ¼ºÀå ÄÚȣƮ ¿¬±¸¿¡¼­ 7~9¼¼ »çÀÌ 90¸íÀÇ ​​¾Æµ¿°ú ¸ð¼ºÀ» ´ë»óÀ¸·Î ¸ð¼ºÀÇ Ç÷¾×¿¡¼­´Â µÎ À¯ÀüÀÚÀÇ ¸Þƿȭ¸¦ ºÐ¼®Çß´Ù. ¾Æµ¿ÀÇ Ç÷¾×¿¡¼­´Â Æ®¸®±Û¸®¼¼¶óÀ̵å(TG) ¼öÁØÀ» ºÐ¼®Çß´Ù.

 

±è¿µÁÖ ÀÌ´ë¸ñµ¿º´¿ø »êºÎÀΰú ±³¼ö
»çÁø=ÀÌ´ë¸ñµ¿º´¿ø

±× °á°ú TG ¼öÁØÀÌ ³ôÀº ¾Æµ¿¿¡¼­´Â TG ¼öÁØÀÌ ³·Àº ¾Æµ¿¿¡ ºñÇØ üÁú·® Áö¼ö°¡ Áõ°¡ÇÏ´Â ¹Ý¸é MC4R°ú HNF4IN À¯ÀüÀÚÀÇ ¸Þƿȭ´Â ³·°Ô ³ªÅ¸³µ´Ù.

 

±è¿µÁÖ ±³¼ö´Â "°ü·Ã ¿¬±¸°¡ µå¹® »óȲ¿¡¼­ À̹ø Ãâ»ý ½Ã Á¦´ëÇ÷ À¯ÀüÀÚÀÇ ¸Þƿȭ º¯È­°¡ ¾î¸° ½ÃÀýÀÇ ½ÅÁø ´ë»ç¿¡ ¿µÇâÀ» Áشٴ ¿¬±¸ °á°ú¸¦ µµÃâÇÑ °ÍÀº ¸Å¿ì Áß¿äÇÏ´Ù"¸ç "À̹ø ¿¬±¸¸¦ ÅëÇØ ÇâÈÄ Á¦´ëÇ÷ÀÇ MC4R°ú HNF4 À¯ÀüÀÚÀÇ ¸Þƿȭ¸¦ ÀÌ¿ëÇØ ¾Æµ¿ÀÇ ºñ¸¸ ¿¹ÃøÀÌ °¡´ÉÇÏ°Ô µÉ °Í"À̶ó°í ¸»Çß´Ù.

 

À̹ø ¿¬±¸´Â À̹ø ¿¬±¸ ³í¹®Àº SCI ±¹Á¦ÇмúÁö <ÀÇÇÐ(Medicine)>ÀÇ ¿Â¶óÀÎ ÆÇ 7¿ùÈ£¿¡ °ÔÀçµÆ´Ù.

 

 

 

******¾Æ·¡´Â ³í¹® ¿øº» ÀϺΠ¹ßÃ麻 (Downloaded from Medicine)

 

MC4R and HNF4a promoter methylation at birth contribute to triglyceride levels in childhood

Kwon, Eun Jin PhD, Lee, Hye Ah PhD, You, Young-Ah PhD, Yoo, Jae Young PhD, Park, Hyesook MD, PhD,  Park, Eun Ae MD, PhD, Ha, Eun Hee MD, PhD, Kim, Young Ju MD, PhD

 

 

Abstract

 

Although the changes in DNA methylation are assumed to be due to the association between adverse intrauterine conditions and adult metabolic health, evidence from human studies is rare. Little is known about the changes in DNA methylation present at birth that affect metabolic profiles in childhood. Previous studies have shown that the melanocortin 4 receptor (MC4R) and hepatocyte nuclear factor 4 alpha (HNF4α) genes are associated with obesity and metabolic disorders. Thus, we investigated the associations of the DNA methylation statuses of MC4R and HNF4α in cord blood with metabolic profiles in childhood.

 

We collected data from 90 children 7 to 9 years of age included in the Ewha Birth & Growth Cohort Study in Korea. DNA methylation was analyzed by pyrosequencing. The children were split into 2 groups according to the cutoff triglyceride (TG) levels (<110 and ≥110 mg/dL).

 

The methylation statuses of MC4R and HNF4α at birth were significantly associated with the TG level in childhood (P < .05). It was interesting to note that the methylation statuses of MC4R and HNF4α in cord blood were significantly decreased, whereas childhood body mass index was significantly increased, in children with high TG levels compared with children with low TG levels (P < .05).

 

Our findings show that the methylation statuses of MC4R and HNF4α at birth are associated with metabolic profiles in childhood. These epigenetic modifications occurring in early life may contribute to subsequent metabolic-related disorders. Thus, we suggest that DNA methylation status in cord blood may be predictive of the risk of developing metabolic syndrome.

 

¡Ø Ãâó :  Medicine


ksh2@healthi.kr

 

#Çコ¾Ø¶óÀÌÇÁ #±è¼ºÈ­±âÀÚ #ÀÌ´ë¸ñµ¿º´¿ø #»êºÎÀΰú #½ÅÁø´ë»ç #ºñ¸¸¿¹Ãø #MC4R #HNF4IN #À¯ÀüÀÚ #¸Þƿȭ #Á¦´ëÇ÷